Why the study?
Does transcatheter mitral valve replacement (TMVR) provide durable resolution of MR and functional improvement in patients with symptomatic MR?
Does transcatheter mitral valve replacement (TMVR) provide durable resolution of MR and functional improvement in patients with symptomatic MR?
In a real-world registry, TMVR provided durable MR resolution and functional improvement at 2 years, though mortality remained high at 38.1%, highlighting the need for optimized patient selection and access site management.
In this real-world registry of patients with symptomatic MR undergoing TMVR, treatment with TMVR was associated with a durable resolution of MR and significant functional improvement at 2 years. Two-year mortality was 38.1%. Optimised patient selection and improved access site management are mandatory to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Ludwig et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: